Camille Turbide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Camille turbide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Camille Turbide Today - Breaking & Trending Today

BRAIN-AF Study Receives Canadian Institutes of Health Research Grant This money will allow for the expansion of remote recruitment of participants for this research that aims to treat the heart and help the brain


Article content
MONTREAL, March 16, 2021 (GLOBE NEWSWIRE) The Montreal Heart Institute (MHI) announces that the BRAIN-AF study has received a $1.4 million grant from the Canadian Institutes of Health Research. Seeking to better understand the effects of cardiovascular disease on the cognitive decline of the brain, the study will be able to recruit participants remotely thanks to this funding.
BRAIN-AF is studying a common heart rhythm disorder called atrial fibrillation (AF). This is the first study in the world to analyze the effects of atrial fibrillation on cognitive decline in young patients up to age 65. “We hypothesize
that cardiac microclots damage the brains of young patients with atrial fibrillation,” says Dr. Lena Rivard, a cardiologist specializing in electrophysiology at the MHI, and the principal investigator of the BRAIN-AF study launched in 2015 with her colleagues, Drs. Denis Roy and Paul Khairy. ....

Denis Roy , Paul Khairy , Lena Rivard , Camille Turbide , Montreal Heart Institute , World Health Organization , Health Canada , Canadian Institutes Of Health Research , Canadian Institutes , Montreal Heart , டெனிஸ் ராய் , பால் கைரி , லீனா போட்டி , மான்ட்ரியல் இதயம் நிறுவனம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆரோக்கியம் கனடா , கனடியன் நிறுவனங்கள் ஆஃப் ஆரோக்கியம் ஆராய்ச்சி , கனடியன் நிறுவனங்கள் , மான்ட்ரியல் இதயம் ,

Colchicine reduces the risk of COVID-19-related complications


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Colchicine reduces the risk of COVID-19-related complications
Montreal Heart InstituteJanuary 23, 2021 GMT
MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The analysis of the 4159 patients in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test has shown that the use of colchicine was associated with statistically significant reductions in the risk of death or hospitalization compared to placebo. In these patients with a proven diagnosis of ....

South Africa , United States , Sophie Desmarais , Jean Claude Tardif , Camille Turbide , Christy Maginn , Montreal Heart Institute , Us National Institutes Of Health , Research Center , Melinda Gates Foundation , Dacima Software Inc , Pharmascience Inc , Montreal Health Innovations Coordinating Center , Blood Institute , National Heart , Principal Investigator , South America , Dacima Software , Electronic Data Capture , Dacima Clinical Suite , Therapeutics Accelerator , Products And Services , Coronavirus Pandemic , Product Testing , Diagnosis And Treatment , Globe Newswire ,